GT Biopharma Provides Second Quarter 2021 Business Update

BEVERLY HILLS, Calif.: BEVERLY HILLS, Calif., Aug. 13, 2021 /PRNewswire/ -- GT Biopharma, Inc. ("GT Biopharma" or the "Company") (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the Company's proprietary natural killer (NK) cell engager (TriKEĀ®) protein biologic technology platform, today provided a general...

Click to view original post